Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PHSYX vs. ETHSX: which is better?

Bottom line

PHSYX vs ETHSX: the short answer

PHSYX (Putnam Global Health Care Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 71% by weight.

But PHSYX is far broader, holding 115 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.

PHSYX is cheaper at 0.79% vs 1.18% — a difference of $39 a year per $10,000 invested.

Over five years, PHSYX returned +8.1% a year vs +5.3% for ETHSX.

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

PHSYX vs ETHSX side by side

PHSYXETHSX
TypeMutual fundMutual fund
Fund familyFranklin TempletonMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.79%1.18%
Annual cost per $10k$79$118
10-yr cost on $10k (prospectus)$978$1,911
Max front load0%5.25%
12b-1 fee0%0.25%
1-yr return+1.5%−1.9%
5-yr return (annualized)+8.1%+5.3%
10-yr return (annualized)+7.8%+6.4%
Best quarter—+14.2%
Worst quarter—−12.1%
Net assets (fund)$1.5B$757.9M
Number of holdings11542
Portfolio turnover67%3%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

16 of PHSYX's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingPHSYXETHSX
Eli Lilly & Co.13.15%12.47%
Johnson & Johnson8.46%6.45%
UnitedHealth Group, Inc.6.93%5.49%
AbbVie, Inc.6.05%6.46%
Novartis AG5.13%1.65%
Merck & Co., Inc.4.88%5.08%
AstraZeneca plc4.67%6.24%
Thermo Fisher Scientific, Inc.4.50%2.79%
Intuitive Surgical, Inc.4.04%2.72%
Sanofi SA3.23%2.95%
Roche Holding AG2.79%5.44%
Gilead Sciences, Inc.2.63%3.34%
Vertex Pharmaceuticals, Inc.1.97%3.38%
Novo Nordisk A/S1.90%1.71%
Boston Scientific Corp.1.80%2.18%

Source: SEC Form N-PORT

PHSYX top 10

  1. Eli Lilly & Co. — 13.15%
  2. Johnson & Johnson — 8.46%
  3. UnitedHealth Group, Inc. — 6.93%
  4. AbbVie, Inc. — 6.05%
  5. Novartis AG — 5.13%
  6. Merck & Co., Inc. — 4.88%
  7. AstraZeneca plc — 4.67%
  8. Thermo Fisher Scientific, Inc. — 4.50%
  9. Intuitive Surgical, Inc. — 4.04%
  10. Sanofi SA — 3.23%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between PHSYX and ETHSX?
PHSYX (Putnam Global Health Care Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 71% by weight. But PHSYX is far broader, holding 115 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.
Which is cheaper, PHSYX or ETHSX?
PHSYX has the lower expense ratio (0.79%).
Should I own both PHSYX and ETHSX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.